Bill > HB667

This bill aims to reduce addiction, overdose, and death related to the use of opioids in Hawaii. It does this by: 1) Requiring patients and prescribers of opioids to execute a written agreement to engage in an informed consent process if the patient requires opioid treatment for more than three months, is prescribed benzodiazepines and opioids together, or is prescribed a high dose of opioids. The informed consent process includes discussing the risks of overdose, the availability of naloxone, non-opioid treatment options, treatment goals, and plans for assessing the patient's risk of abuse. 2) Limiting initial prescriptions for opioids and benzodiazepines to a maximum of seven consecutive days, except for the treatment of pain associated with cancer, palliative care, or hospice care, if the prescriber documents the medical condition and that a non-opioid alternative is not appropriate.

Health and Social Services, Justice

http://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=HB&billnumber=667&year=2017